ALK and non-small cell lung carcinoma: A 70-year-old man with advanced NSCLC and metastases to the lung and brain underwent standard tissue hotspot testing for EGFR, ALK, and ROS 1, with no actionable alteration detected in EGFR, ALK, or ROS1.